We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Three Complications Responsible for Half of Noncardiac Surgery Deaths

By HospiMedica International staff writers
Posted on 06 Aug 2019
Major bleeding, myocardial injury, and sepsis account for almost 45% of deaths occurring after noncardiac surgery, according to a new study.

Researchers at McMaster University (Hamilton, ON, Canada), Groote Schuur Hospital (Cape Town, South Africa), Jagiellonian University (Krakow, Poland), and other institutions in 14 countries conducted a prospective cohort study of 40,004 patients aged 45 years and older who underwent inpatient noncardiac surgery so as to examine the frequency and timing of death and its association with perioperative complications. More...
The patients were monitored for complications until 30 days after surgery.

The results revealed that overall, 1.8% of the patients died within 30 days of surgery. Of these, 0.7% of deaths occurred in the operating room; 69.9% occurred after surgery, during the index admission to the hospital; and 29.4% occurred after discharge from the hospital. Independent associations were found between eight complications and 30-day mortality. Major bleeding (17%), myocardial injury (15.9%), and sepsis (12%) had the largest attributable fractions. The study was published on July 29, 2019, in the Canadian Medical Association Journal (CMAJ).

“We identified eight perioperative complications independently associated with 30-day mortality. Three of these complications could explain 44.9% of the deaths. These complications are promising targets for research on prevention, early identification, and management to decrease perioperative mortality,” concluded lead author Jessica Spence, MD, of McMaster University, and colleagues. “Given that 99.3% of deaths among adults undergoing noncardiac surgery occur after the procedure, efforts to improve postsurgical care have the potential to reduce mortality.”

Patients are vulnerable to major adverse outcomes and a broad range of illnesses after hospital stay, and this period of heightened and generalized vulnerability to a spectrum of conditions has been called the post-hospital syndrome. Readmissions are common with nearly one in five adults aged more than 65 readmitted within 30 days of discharge. Death is also common in this first month, during which rates of post-discharge mortality may exceed those of initial inpatient mortality.

Related Links:
McMaster University
Groote Schuur Hospital
Jagiellonian University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.